Oxford Science Enterprises — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
BibliU is a digital learning platform that partners with publishers to provide students affordable, instant access to course content, and offers institutions workflow automation to reduce administrative burden.
EdTechSaaS
Dave Sherwood(CEO & Co-Founder)in
Co-investorsBrick Capital VenturesGreen Shores CapitalGuinness VenturesKreos CapitalOxford Investment Opportunity NetworkOxford Investment Opportunity Network (OION)+7 more
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsM VenturesPfizer Venture InvestmentsBritish Patient CapitalJJDCPfizer Ventures
ONI develops the Nanoimager, an automated super-resolution imaging system.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Paul Scagnetti(Chief Executive Officer)in
Co-investorsAnjostARCH Venture PartnersArtis VenturesFuture Planet CapitalOxford Technology ManagementVertical Venture Partners+6 more
PQShield develops post-quantum cryptography (PQC) products, including optimized software libraries, SDKs, OpenSSL integration layers, and lattice-based hardware IP cores, to help organizations migrate systems to quantum-resistant cryptography.
CybersecurityDeep TechQuantum ComputingSemiconductors
Co-investorsBY Venture PartnersCrane Venture PartnersKindred CapitalAdditionChevron Technology Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

.avif)











